Pabau GO app

Ya está aquí el nuevo Pabau GOdescarga en el App Store

Download on the App Store
Reservar demo Reservar demo
Billing Codes

HCPCS code C1899: Lead, pacemaker/defibrillator combination implantable

Foto del avatar Maja Popovska
Last Updated: agosto 11, 2026
Key takeaways

Key takeaways

HCPCS code C1899 covers a single implantable lead that both paces the heart and delivers defibrillation shocks.

C1899 is an HCPCS Level II C-code, used only by hospital outpatient departments billing under the Outpatient Prospective Payment System.

The status indicator in CMS Addendum B decides whether Medicare packages the lead into the procedure payment or pays for it separately.

Dollar amounts for 2026 have to be verified against Addendum B, because rates change with every annual OPPS Final Rule.

Practice management software like Pabau helps billing teams track OPPS device codes, catch missing documentation, and reduce denials.

HCPCS code C1899 covers a lead, pacemaker/cardioverter-defibrillator combination implantable. It describes one implanted lead that delivers pacing impulses and defibrillation shocks from the same component. Hospital outpatient departments report it under the Outpatient Prospective Payment System (OPPS), and nowhere else.

This reference covers the code description, its attributes, and 2026 fee schedule context. It also covers OPPS billing rules, Medicare coverage, and the codes most often mistaken for it. Claims management software built for outpatient billing can catch a mismatched device code before the claim goes out.

HCPCS code C1899: Description and device covered

HCPCS code C1899 describes a lead, pacemaker/cardioverter-defibrillator combination implantable. Its short description, used in claim processing systems, is «Lead, pmkr/aicd combination.» The code sits in HCPCS Level II, the alphanumeric set maintained by the Centers for Medicare and Medicaid Services (CMS). That set covers supplies and devices CPT codes do not.

C-prefix codes within HCPCS Level II are temporary codes for new technology and high-cost devices used in the hospital outpatient setting. C1899 belongs to the Assorted Devices, Implants, and Systems range (C1760-C2615), per the AAPC HCPCS code range classification.

Other HCPCS Level II families follow a different payment path entirely. Durable medical equipment codes such as E0293 and K0046 are billed to a durable medical equipment contractor rather than through OPPS.

Field Value
HCPCS code C1899
Short description Lead, pmkr/aicd combination
Long description Lead, pacemaker/cardioverter-defibrillator combination implantable
Code type HCPCS Level II (C-code)
Code category Assorted Devices, Implants, and Systems (C1760-C2615)
Applicable setting Hospital outpatient department (OPPS only)
2026 active status Active (verify against current CMS quarterly update)

The combination designation carries clinical weight. Some patients with advanced cardiac conditions need both functions in one device. It has to pace a heart beating too slowly and shock a dangerously abnormal rhythm back into line.

A single lead covering both jobs is distinct from a defibrillator-only lead such as C1895 or C1896. It is also distinct from C1898, the dedicated pacemaker lead code. Code choice follows what the implanted lead does, not what the system is called.

C1899 code attributes and OPPS status indicator

Every HCPCS C-code carries a set of attributes that determine how Medicare pays for it under OPPS. The status indicator (SI) is the field to check first in the CMS OPPS Addendum B each year. It dictates the payment method for the whole line.

According to CMS’s HCPCS overview, C-codes are maintained by CMS and updated through the annual OPPS Final Rule.

Attribute Detail Why it matters
Status indicator (SI) Verify in current CMS Addendum B Determines whether OPPS pays separately or bundles payment
APC assignment Verify in current CMS Addendum B Sets the payment group rate for the outpatient encounter
Code effective date Verify against CMS HCPCS quarterly update files Confirms the code is valid for the date of service
Billing setting Hospital outpatient department only C-codes are not valid for ASC or physician office claims
Payment system OPPS (Outpatient Prospective Payment System) APC group drives the Medicare allowed amount

Outdated Addendum B files are the most common source of status indicator errors. CMS publishes the OPPS Final Rule each November with APC and SI updates effective January 1. Quarterly updates can also change individual codes between annual cycles, so pull the current Addendum B from CMS before billing.

2026 fee schedule and Medicare reimbursement for HCPCS code C1899

Medicare reimbursement for C1899 is set under OPPS through the Ambulatory Payment Classification (APC) group assigned to the code. The APC rate is a composite payment for the outpatient encounter grouped to that APC, rather than a flat per-unit price for the lead.

Rates change annually with the Final Rule, so pull the 2026 amount from the current CMS HCPCS code list or Addendum B.

Third-party fee schedule tools give useful ballpark ranges, but they are not the authoritative source for claim submission. The table below outlines the payment factors that decide what a hospital is actually paid.

Payment factor Details Source to verify
OPPS APC rate Set annually by CMS Final Rule CMS OPPS Addendum B (current year)
Geographic adjustment Wage index applied by locality CMS OPPS wage index tables
Medicare patient liability 20% coinsurance of APC rate (after deductible) Medicare Benefit Policy Manual
Device credit rules A manufacturer credit on a replaced device can trigger CMS no-pay or reduced-pay rules CMS Claims Processing Manual, Chapter 4
Non-Medicare payers Rates vary by payer contract, and OPPS rates do not bind commercial plans Payer-specific fee schedules and contracts

For commercial payers, reimbursement on implantable cardiac device codes is usually governed by the hospital’s own contract rather than OPPS. Check the payer-specific fee schedule and confirm whether prior authorization is required before the implant is performed. Solid EHR integration between implant tracking and the billing platform shortens the lag between implant date and claim submission.

Pro Tip

Pull the CMS OPPS Addendum B for each calendar year directly from cms.gov before you update the charge master for C-codes. Third-party fee schedule databases often lag CMS by several weeks after the Final Rule is published. Stale rates on high-cost device claims like C1899 create underpayments that are hard to correct after the fact.

Billing guidelines for HCPCS C1899

C1899 is restricted to hospital outpatient department claims submitted under OPPS. Physician offices, ambulatory surgery centers, and inpatient settings do not use HCPCS C-codes for this device category. The rules below apply to hospital outpatient coders working Medicare claims.

  • Provider type: Hospital outpatient departments only. C-codes are not valid outside OPPS-participating facilities.
  • Bill type: Reported on a UB-04 claim form (837I transaction) with the appropriate revenue code and the facility’s Type 2 NPI.
  • Units: Report one unit per lead implanted. Two combination leads placed in the same encounter means two units of C1899.
  • Device credits: When a hospital receives a manufacturer credit for a replaced device, CMS no-pay and reduced-payment rules may apply. Check the Medicare Claims Processing Manual, Chapter 4, for the current no-pay threshold.
  • Modifier use: Confirm with current CMS guidance whether any modifiers are required or prohibited with C1899. Modifier requirements can change with annual OPPS updates.
  • Bundling: The status indicator decides whether the device cost is packaged into the procedural APC or paid separately. An SI of «N» means the payment is packaged.

Documentation supporting the claim should identify the implanted lead as a combination pacemaker/cardioverter-defibrillator lead in plain terms. Operative reports, implant stickers, and device tracking logs are what Medicare auditors look for when they review a C-code claim.

Paperless documentation practices that capture implant data electronically make that audit trail far easier to hold together.

Teams handling high volumes of cardiac device cases benefit from a workflow that links the operative report straight to the charge capture event. Practice management software features built for multi-provider outpatient facilities can automate part of that link. A device then cannot be implanted and missed at billing.

Cardiac procedure records are protected health information, so the platform holding them has to meet HIPAA compliance standards for storage and access.

Medicare coverage and payer policy for HCPCS code C1899

Medicare covers implantable cardiac leads, including combination pacemaker/defibrillator leads, when the implant is medically necessary for a covered indication. Coverage sits under Local Coverage Determinations (LCDs) and National Coverage Determinations (NCDs). Those documents set out the clinical criteria a patient must meet before a pacemaker or ICD goes in.

Confirm that the documented indication in the medical record lines up with the applicable LCD or NCD before you submit. That indication reaches the claim as a diagnosis code. A documented episode of syncope is reported as R55, or the more specific code the physician supports.

The coverage considerations below apply to most Medicare claims for C1899.

  • Medical necessity: The physician’s documentation has to support the diagnosis and the decision to implant a combination lead. Undocumented medical necessity is the leading reason Medicare denies implantable cardiac device claims.
  • LCD review: Check whether the Medicare Administrative Contractor (MAC) for your jurisdiction has issued an LCD on cardiac rhythm management devices. MACs such as Noridian and CGS publish cardiac device coding articles that supplement national guidance.
  • ABN requirements: Issue an Advance Beneficiary Notice of Noncoverage before the service. That applies whenever Medicare may not cover the procedure for a given patient.
  • Secondary payers: When Medicare is the secondary payer, the primary insurer’s determination and Explanation of Benefits are needed before the Medicare claim processes.

Commercial payers do not follow OPPS methodology and are not bound by CMS coverage determinations. Review each plan’s coverage policy for implantable cardiac leads before the procedure, with particular attention to prior authorization.

The NLM’s HCPCS Level II API is a free lookup resource for verifying code attributes when you build C-code data into payer verification workflows.

Understanding the pacemaker/cardioverter-defibrillator combination lead

The device behind C1899 is a single transvenous lead engineered to deliver both cardiac pacing impulses and high-energy defibrillation shocks. That dual capability matters for coding, because one implanted component removes the need to report two separate leads.

Clinically, combination leads appear in patients receiving a cardiac resynchronization therapy defibrillator (CRT-D) or an implantable cardioverter-defibrillator (ICD) system that also provides backup pacing.

The lead connects the pulse generator to heart tissue, sensing intrinsic cardiac activity and delivering therapy as needed. For hospital coders, the deciding fact is the type of lead implanted and documented in the operative report. The generator model does not settle the code choice.

When you review procedure documentation, look for these signs that C1899 is the right code:

  • The operative report describes a single lead placed in the right ventricle, or another chamber, carrying both pacing and shocking electrode coils
  • The implant sticker or device identifier confirms a «combination» or «integrated» lead model
  • The physician documents an ICD or CRT-D system with one combination lead instead of separate pacing and sensing leads

Identifying the lead type at charge capture heads off a common error. Coders reach for a defibrillator-only lead code such as C1895 or C1896, or the pacemaker-only code C1898, when a combination lead went in.

Facilities that track implantable device inventory through their medical forms can cross-reference device lot numbers against manufacturer specifications and confirm the lead category before coding.

The most frequent error involving C1899 is picking an adjacent cardiac lead code when the device warrants C1899. The table below compares the codes coders confuse most often in this range.

HCPCS code Description Key differentiator
C1899 Lead, pacemaker/cardioverter-defibrillator combination implantable Single lead with both pacing and defibrillation capability
C1895 Lead, cardioverter-defibrillator, endocardial dual coil (implantable) Defibrillator lead with two shocking coils, no combination role
C1896 Lead, cardioverter-defibrillator, other than endocardial single or dual coil (implantable) Defibrillator lead outside the endocardial single and dual coil types
C1898 Lead, pacemaker, other than transvenous VDD single pass The dedicated pacemaker lead code, with no defibrillation function
C1900 Lead, left ventricular coronary venous system CRT pacing lead placed in the coronary sinus, not a defibrillator lead
C1882 Cardioverter-defibrillator, other than single or dual chamber (implantable) A generator code rather than a lead code, and distinct from C1899

C1899 and C1896 collide most often, because both describe defibrillator leads. C1896 covers a defibrillator lead with no pacing capability, while C1899 covers a lead that does both jobs.

When a coder is unsure, the implant sticker on the operative report carries the manufacturer’s product number. Run that number against the manufacturer’s product catalog to confirm whether the lead is a combination type.

How OPPS and APC assignment affect C1899 payment

OPPS pays hospital outpatient claims by grouping each reported HCPCS code into an Ambulatory Payment Classification. The APC sets the base payment rate for the encounter. For a device code like C1899, the status indicator in Addendum B is the variable that moves the money.

An SI of «N» means the device cost is packaged into the procedural APC and not paid separately. An SI of «J1,» «J2,» or «S» signals a comprehensive or separately payable APC. Here is how each one plays out:

  • Packaged (SI = N): The hospital gets no separate line-item payment for C1899. The APC rate for the implant procedure code on the same claim is expected to cover the lead.
  • Separately payable (SI = J1, J2, or S): C1899 generates its own APC payment on top of the procedural APC. This is more common for high-cost items that the procedural rate alone does not cover.
  • Pass-through payment (SI = H): A temporary status for new technology devices, paying on top of the APC rate while CMS gathers cost data. C-codes often hold this status when first assigned.

Charge master teams should audit the SI for C1899 each year when the OPPS Final Rule lands, and again after every quarterly update. A mismatch between the charge master assumption and the published SI repeats across every cardiac implant case using that code.

The Medicare Informatics HCPCS tables are a useful cross-reference for checking SI assignments across HCPCS code ranges.

Some hospitals run several high-cost implantable device lines at once. A charge capture process that ties each HCPCS code to its current APC and SI cuts both underpayment exposure and overpayment risk on audit. Keeping procedure code fee schedules current across the billing infrastructure is one practical way to hold that line.

Pro Tip

Audit your charge master for C1899 and the adjacent C-codes every January, once the OPPS Final Rule takes effect. Compare each code’s status indicator in your system against the current CMS Addendum B file. One wrong SI assumption on a high-volume cardiac implant code compounds fast. It can create tens of thousands of dollars in billing errors within a quarter.

Code history and annual updates for HCPCS code C1899

HCPCS C-codes for implantable devices are updated through the annual CMS OPPS Final Rule cycle, with mid-year revisions possible via quarterly HCPCS updates. C1899 is listed as active for 2026 Medicare billing on third-party HCPCS reference platforms. Verify the effective date and active status against the CMS quarterly update files before you rely on any single source.

Update type Timing What to review
Annual OPPS Final Rule Published November, effective January 1 APC assignment, status indicator, payment rate, device credit rules
Quarterly HCPCS updates January, April, July, October New codes, code revisions, terminations affecting the C1899 range
OPPS Addendum B update Updated with the Final Rule, and midyear if needed Per-code SI, APC, and payment amount for each HCPCS code
MAC coding articles Issued as needed by regional MACs Local coverage instructions and documentation requirements by jurisdiction

Build a scheduled HCPCS code review that covers all four quarterly windows. Name one coding compliance lead to read the CMS release notes each quarter. That keeps charge master updates for codes like C1899 ahead of the claims going out.

Connect the charge master to a solid EMR software platform and parts of that update cycle automate themselves. That takes manual review off the coding team.

How Pabau keeps implant documentation and device claims in step

In most outpatient settings, the implant record and the claim live in different systems. Someone scans the implant sticker into the procedure record. Someone else rekeys the device into the charge system. Every hand-off is another chance for the lead type to land wrong.

Practice management software like Pabau keeps the clinical record and the billing record in one place. Digital forms capture implant details at the point of procedure and attach them to the patient file immediately. The charge and its supporting documentation then point at the same record, so nobody matches them up by hand a week later.

The same problem shows up well outside cardiology. Pabau supports outpatient teams from primary care to physical therapy, where device follow-up, coding, and coverage checks sit with a small admin team.

What that buys you is a shorter path from procedure to submitted claim. It also leaves an audit trail that already holds what a Medicare reviewer will ask for, rather than one assembled after the request arrives.

Reduce claim denials on high-cost device codes

Pabau’s claims management tools track OPPS device code submissions and catch missing documentation before claims go out. Your team keeps an audit-ready trail for every high-value implantable cardiac procedure.

Pabau claims management dashboard

Conclusion

Getting C1899 right comes down to one habit. Read the operative report before you pick the code. The system name on the implant box will not tell you whether the lead paces, shocks, or does both. That single fact decides between four adjacent codes.

The second habit runs on a calendar. Check the status indicator and APC in the current Addendum B every January, then again after each quarterly update. A charge master carrying last year’s assumption repeats the same error on every cardiac implant case it touches.

Both habits depend on implant documentation reaching the billing team intact. When the procedure record and the charge sit in one system, that is one less thing to chase at month end. Book a demo to see how Pabau handles device documentation and claim submission for high-cost implants.

Continue your research

Continue your research

Need to understand how billing codes interact with compliance documentation? HIPAA compliance for medical offices covers the documentation and data security requirements behind clean claims for cardiac procedure records.

Working out which NPI belongs on a facility claim? Type 1 vs Type 2 NPI explains which identifier goes where, and what happens when the wrong one reaches the payer.

Billing a HCPCS Level II drug code this quarter? J1322 walks through units, documentation, and payer rules for the J-code side of HCPCS Level II.

Looking for guidance on procedure code fee schedules across payer types? CPT coding reference sets out how procedure codes and fee schedules interact across different billing settings.

Frequently asked questions

What does HCPCS code C1899 describe?

HCPCS code C1899 covers a lead, pacemaker/cardioverter-defibrillator combination implantable. It is a single transvenous lead that delivers both cardiac pacing and defibrillation. The code is HCPCS Level II, used by hospital outpatient departments billing under the Outpatient Prospective Payment System.

Is HCPCS code C1899 covered by Medicare?

Yes. Medicare covers implantable cardiac leads, including combination pacemaker/defibrillator leads, when medical necessity is documented. The implant also has to meet the criteria in the applicable Local Coverage Determination or National Coverage Determination. Review the MAC-specific LCD for cardiac rhythm management devices before submitting the claim.

When should C1899 be used instead of C1896?

Use C1899 when the operative report and implant sticker confirm a single lead providing both pacing and defibrillation. Use C1896 when the implanted lead is a cardioverter-defibrillator lead with no pacing function. Confirm the lead type against the manufacturer’s product catalog rather than the system name alone.

What is the 2026 fee schedule rate for C1899?

The 2026 rate follows the APC assignment published in the CMS OPPS Addendum B for the 2026 Final Rule. Amounts vary by APC group and geographic wage index. Pull the current Addendum B directly from CMS, since third-party fee schedule databases may not carry the latest quarterly updates.

What OPPS status indicator applies to C1899?

Verify the status indicator for C1899 in the current CMS OPPS Addendum B, because it can change with annual or quarterly updates. The SI decides whether payment for the device is packaged into the procedural APC or paid separately. An outdated SI in the charge master is a common source of systematic billing errors.

How do hospital outpatient departments bill for HCPCS code C1899?

Hospital outpatient departments report C1899 on a UB-04 claim with the appropriate revenue code, one unit per combination lead implanted. The claim should be supported by the operative report, the implant device sticker, and documentation confirming the lead’s combination function. Device credit rules from Chapter 4 of the CMS Claims Processing Manual apply when a manufacturer credit was received.

×